Anthem Inc (A58) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Anthem Inc (A58) has a cash flow conversion efficiency ratio of 0.002x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€84.00 Million) by net assets (€44.03 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Anthem Inc - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Anthem Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Anthem Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Anthem Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
London Stock Exchange Group plc
PINK:LDNXF
|
0.064x |
|
Marathon Petroleum Corp
NYSE:MPC
|
0.109x |
|
Mitsubishi Corporation
OTCGREY:MTSUY
|
0.036x |
|
Manulife Financial Corp
NYSE:MFC
|
0.164x |
|
Wesfarmers Ltd
AU:WES
|
0.317x |
|
Atlas Copco AB
PINK:ATLFF
|
0.063x |
|
Rheinmetall AG
PINK:RNMBF
|
0.015x |
|
National Australia Bank Ltd
PINK:NAUBF
|
0.165x |
Annual Cash Flow Conversion Efficiency for Anthem Inc (2015–2025)
The table below shows the annual cash flow conversion efficiency of Anthem Inc from 2015 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €44.03 Billion | €4.29 Billion | 0.097x | -30.50% |
| 2024-12-31 | €41.43 Billion | €5.81 Billion | 0.140x | -41.93% |
| 2023-12-31 | €39.41 Billion | €9.51 Billion | 0.241x | +4.62% |
| 2022-12-31 | €36.39 Billion | €8.40 Billion | 0.231x | -0.32% |
| 2021-12-31 | €36.13 Billion | €8.36 Billion | 0.232x | -28.09% |
| 2020-12-31 | €33.20 Billion | €10.69 Billion | 0.322x | +68.53% |
| 2019-12-31 | €31.73 Billion | €6.06 Billion | 0.191x | +42.47% |
| 2018-12-31 | €28.54 Billion | €3.83 Billion | 0.134x | -15.08% |
| 2017-12-31 | €26.50 Billion | €4.18 Billion | 0.158x | +21.21% |
| 2016-12-31 | €25.10 Billion | €3.27 Billion | 0.130x | -28.72% |
| 2015-12-31 | €23.04 Billion | €4.21 Billion | 0.183x | -- |
About Anthem Inc
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad… Read more